Table 1 Numbers of patients with plasma HIV-1 RNA concentration < 50 copies/ml at each study visit, by reason for switch to TDF/FTC (n (%))
Reason for switch of therapy | ||||
|---|---|---|---|---|
Side effects* (N = 19) | Simplify regimen (N = 26) | Both (N = 6) | Total (N = 51) | |
Week 4 | 18 (95) | 25 (96) | 5 (83) | 48 (94) |
Week 12 | 19 (100) | 23 (88) | 5 (83) | 47 (92) |
Week 24 | 19 (100) | 20 (77) | 4 (67) | 43 (84) |
Week 36 | 18 (95) | 18 (69) | 3 (50) | 39 (76) |
Week 48 | 15 (79) | 21 (81) | 4 (67) | 40 (78) |